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Abstract Actin bound to the adenovirus proteinase (AVP) with
a lower equilibrium dissociation constant, 4.2 nM, than those
exhibited by two viral, nuclear cofactors for AVP, the 11-amino
acid peptide pVIc and the viral DNA. The kcat/Km ratio for
substrate hydrolysis by AVP increased 150 000-fold in the pres-
ence of actin. The 11-amino acid residue peptide corresponding
to the C-terminus of actin, which is highly homologous to pVIc,
bound to AVP and stimulated its activity in the presence of
DNA. As a cellular cofactor for AVP, AVP(actin) complexes
may facilitate the cleavage of cytoskeletal proteins, preparing
the infected cell for lysis and release of nascent virions.
- 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Recently, actin was shown to be able to act in vitro as a
cofactor for the adenovirus proteinase (AVP) in the degrada-
tion of cytoskeletal proteins [1]. Studies of infection of HeLa
cells by adenovirus [2] or transfection of HeLa cells by AVP
[1] reveal AVP localizes with cytokeratin 18, and this is then
followed by destruction of the cytokeratin network. For AVP
to cleave cytokeratin 18, a cellular cofactor is required, be-
cause AVP is synthesized as an inactive proteinase. These and
other data implied that a reversible complex between AVP
and actin (AVP(actin) complex) may be involved in the cleav-
age of structural proteins in the cytoplasm that prepares an
infected cell for lysis and release of nascent virions [3].
Late in human adenovirus infection, AVP becomes acti-
vated inside young virions and cleaves multiple copies of six
virion precursor proteins (pTP, pVI, pVII, pVIII, IIIa, and an
11-kDa protein) 3200 times to render virus particles infectious
[4]. AVP requires viral cofactors for maximal enzyme activity
^ pVIc, the 11-amino acid peptide from the C-terminus of
virion precursor protein pVI [5,6], and the viral DNA [5].
The cofactors bind to AVP and in doing so dramatically in-
crease the kcat/Km ratio for substrate hydrolysis [7]. pVIc
binds to AVP through the formation of 30 hydrogen bonds
and a disul¢de bond between Cys10P of pVIc and Cys104 of
AVP [8], as revealed in the crystal structure of AVP bound to
pVIc [9,10]. The binding of DNA to AVP is not dependent
upon any speci¢c sequence in DNA.
Actin was considered a potential cofactor for AVP, because
the C-terminal amino acid sequence of actin (SGPSIV-
HRKCF) [11,12] is highly homologous to the amino acid se-
quence of pVIc (GVQSKLRRRCF) [5,6]. Of the last eight
amino acid residues of actin, four are identical and three
homologous to the last eight amino acid residues of pVIc.
Comparison of the last 10 amino acid residues at the C-ter-
minus of the K-, L-, and Q-isomers of actin reveals that these
residues are strictly conserved. The penultimate amino acid in
actin is Cys374. The penultimate amino acid in pVIc, Cys10P,
is a major determinant in the reversible binding of pVIc to
AVP [13]. Furthermore, a disul¢de bond forms between
Cys10P of pVIc and Cys104 of AVP, both in vitro [9] and in
vivo in the virus particle [14]. In vitro, the enzymatic activity
of AVP is greatly stimulated by actin [1]. AVP appears to
bind to the C-terminus of actin, because AVP can quench
the £uorescence of PRODAN covalently bound to Cys374
of actin.
That actin can be a cofactor for AVP may have resolved a
conundrum. AVP had been shown in vivo to be responsible
for cleavage of cytokeratin 18 in the cytoplasm of adenovirus-
infected cells [2]. However, because AVP had also been shown
to be relatively inactive in vitro in the absence of cofactors
[5,6], the question arose as to whether AVP required a cofac-
tor to cleave cytokeratin 18. AVP could not cleave cytokeratin
18 in vitro. However, in the presence of actin, an AVP(actin)
complex could cleave cytokeratin 18. Also, actin itself is a
substrate for AVP [1] ; in the presence of actin, AVP(actin)
complexes cleave actin at two AVP consensus cleavage sites.
Here we quantitatively characterize the interaction of AVP
with actin. The equilibrium dissociation constant, Kd, was
determined as well as the macroscopic kinetic constants for
substrate hydrolysis. Based upon the Kd and the kcat/Km val-
ues, actin was a better cofactor than pVIc. Finally, the peptide
with the sequence of the last 11 amino acids of actin was
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shown to stimulate AVP, in the presence of DNA. This di-
rectly demonstrated that AVP can bind to the C-terminus of
actin.
2. Materials and methods
2.1. Materials
Bovine thymus G-actin, a gift from Dr. C. Shutt, was puri¢ed ac-
cording to the method of Rozycki et al. [15]. Tris^HCl, EDTA,
DNase I, lysozyme, chloramphenicol, isopropyl-L-D-thiogalactopyra-
noside, and 5,5P-dithio-bis(2-nitrobenzoate) were purchased from Sig-
ma (St. Louis, MO, USA). Octylglucoside was purchased from Roche
Molecular Biochemicals (Indianapolis, IN, USA). The viral peptide
pVIc (GVQSLKRRRCF), 11-Actin-C (SGPSIVHRKCF), and the
Random-Sequence-Peptide (SFRRCGLRQVK) were purchased
from Research Genetics (Huntsville, AL, USA). Reduce-Imm Column
and bu¡ers were purchased from Pierce (Rockford, IL, USA). The
plasmid pT7AD23K8 was from Dr. Carl Anderson. T7 DNA was a
gift from Dr. John Dunn. DEAE and S-Sepharose were purchased
from TosoHaas (Montgomeryville, PA, USA). The £uorogenic sub-
strate (Leu-Arg-Gly-Gly-NH)2-rhodamine was synthesized and puri-
¢ed as described [5,16].
2.2. Determination of protein concentration
Protein concentration was determined by the BCA protein assay
from Pierce. For the concentration of AVP, a calculated molar ab-
sorbance coe⁄cient at 280 nm of 26 510 M31 cm31 was used [17]. For
the concentration of actin, a molar absorbance coe⁄cient at 290 nm
of 26 600 M31 cm31 was used [18].
2.3. Determination of peptide concentrations
The concentrations of peptides were determined by measuring their
thiolate anion concentrations. Prior to an assay, the peptides were
reduced by passage through a Reduce-Imm column following the
manufacturer’s instructions. Assays were performed in 0.516 ml of
50 mM sodium phosphate (pH 8.1) and 1 mM EDTA, containing
350 WM 5,5P-dithio-bis(2-nitrobenzoate) and either pVIc, 11-Actin-C,
or Random-Sequence-Peptide. Reactions were incubated at 25‡C for
10 min before the absorbance at 412 nm was measured. The concen-
tration of thiolate anion was calculated by subtracting the absorbance
in an assay lacking peptide from that measured in its presence, using a
molar extinction coe⁄cient for thionitrobenzoate at 412 nm of 14 150
[19].
2.4. Expression and puri¢cation of AVP
The plasmid pT7AD23K8 was transfected into Escherichia coli
strain BL21(DE3)pLysS. Cells were grown in M9TBYG broth
(0.1% NH4Cl, 0.3% KH2PO4, 0.6% Na2PO4, 0.4% glucose, 1 mM
MgSO4, 0.1% yeast extract, 1% Bacto Tryptone, and 0.5% NaCl)
with 50 Wg/ml ampicillin and 25 Wg/ml chloramphenicol. When the
cells reached an OD600 of 0.500, transcription of the recombinant
gene was induced with 0.6 mM isopropyl-L-D-thiogalactopyranoside.
The cells were harvested 16 h later. The cells were centrifuged at
9000Ug for 10 min at 4‡C. The cells in the pellet were resuspended
in 20 mM Tris^HCl (pH 7.5), 100 mM NaCl, and 0.1% Triton and
stirred for 1 h at 4‡C. Then, 1 mM EDTA and 100 Wg/ml lysozyme
were added, and stirring was continued for an additional hour. MgCl2
to 6 mM was added, and the DNA was digested by the addition of 50
Wg/ml DNase I. After stirring for 1 h at 4‡C, the cell lysate was shell
frozen and thawed three times. Then, the cell lysate was centrifuged at
9000Ug for 10 min at 4‡C.
The supernatant was removed, and its NaCl concentration in-
creased to 200 mM. It was added to 50 ml of DEAE-Sepharose beads
equilibrated in 20 mM Tris^HCl (pH 7.5), 200 mM NaCl, and 0.1%
Triton X-100. The slurry was repeatedly inverted for 25 min at 4‡C,
after which it was ¢ltered through a sintered glass funnel. The £ow-
through was loaded onto a Chelating Sepharose column (Amersham
Pharmacia, Piscataway, NJ, USA) charged with ZnCl2. The protein-
ase eluted from the column in 15 mM EDTA, 20 mM Tris^HCl (pH
7.5), 0.1 M NaCl and 0.1% Triton X-100.
The eluate was diluted to a NaCl concentration of 40 mM, L-mer-
captoethanol was added to 5 mM, and the eluate was loaded onto a S-
Sepharose column. AVP eluted from the S-Sepharose column in 20
mM Tris^HCl (pH 7.5), 200 mM NaCl, and 1 mM octylglucoside.
The protein was dialyzed against nitrogen-saturated bu¡er consisting
of 10 mM Tris (pH 7.5), 5 mM NaCl, 1 mM octylglucoside and 0.1
mM EDTA and stored at 380‡C.
2.5. Assay for proteinase activity
Standard assays in 1 ml contained 10 mM Tris^HCl (pH 8.0) and
5 mM octylglucoside. Proteinase and cofactor(s) were preincubated
for 5 min at 37‡C, £uorogenic substrate (Leu-Arg-Gly-Gly-NH)2-rho-
damine was added, and the increase in £uorescence as a function of
time was measured using an ISS PC-1 £uorometer (Urbana, IL, USA)
with an excitation wavelength of 492 nm and emission wavelength of
523 nm, both with a band pass of 8 nm.
2.6. Calculation of the equilibrium dissociation constant (Kd)
The Kd for the binding of actin to AVP was calculated as follows:
increasing concentrations of actin, [Actin]i, were added to a constant
amount of AVP, [AVP]o. After 5 min at 37‡C, the £uorogenic sub-
strate was added and the increase in £uorescence with time, Fi, mea-
sured. A plot of Fi versus [Actin]i yielded a rectangular hyperbola.
From this graph, the concentration of actin that bound to AVP,
[Actin]bound, was obtained:
½Actinbound ¼ ½AVPo ðF i=FmaxÞ
where Fmax is the maximal rate of substrate hydrolysis, i.e. the rate
when AVP is saturated with actin. The concentration of actin not
bound to AVP, [Actin]free, was determined as follows:
½Actinfree ¼ ½Actini3½Actinbound
The data were plotted as [Actin]bound versus [Actin]free, and from that,
the Kd was determined using GRAFIT [20]. The Kd values for the
binding of pVIc to AVP and of pVIc or 11-Actin-C to AVP(DNA)
complexes were determined in the same manner.
3. Results
3.1. Kd for the binding of actin to AVP
The equilibrium dissociation constant, Kd, for the binding
of actin to AVP was measured. This was done by adding
increasing concentrations of actin to a constant amount of
AVP and measuring the rate of substrate hydrolysis. A plot
of the rate of change in £uorescence versus the actin concen-
tration gave a rectangular hyperbola (Fig. 1). The data in
Fig. 1 were then converted to concentrations of [Actin]bound
and [Actin]free as described in Section 2.6, and, from a plot of
Fig. 1. Binding of actin to AVP, measurement of the Kd. The indi-
cated concentrations of actin were added to a constant amount of
AVP, 2 nM. After incubation for 5 min at 37‡C, (Leu-Arg-Gly-Gly-
NH)2-rhodamine was added to 3 WM and the change in £uorescence
(counts/s) with time (/s) measured. From these data, a Kd for the
binding of actin to AVP was determined, as described in Section 2.
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[Actin]bound versus [Actin]free (data not shown), an apparent
Kd of 4.2 U 0.8 nM was obtained.
3.2. Stoichiometry of binding of actin to AVP
The method used to calculate the Kd assumed the stoichi-
ometry of binding of actin to AVP was 1:1. This 1:1 ratio was
veri¢ed by measuring the stoichiometry of binding under tight
binding conditions, e.g. at AVP concentrations 15^30 times
higher than the apparent Kd. AVP was incubated with in-
creasing concentrations of actin and the rate of substrate hy-
drolysis measured. As the actin concentration was increased,
below the concentration of actin binding sites on AVP, no free
actin was present and the rate of substrate hydrolysis was
directly proportional to the concentration of actin. When
the actin concentration exceeded that of the actin binding sites
on AVP, no further increase in the rate of substrate hydrolysis
was observed. The data were characterized by two straight
lines whose intersection re£ected the minimal concentration
of actin required to saturate AVP (Fig. 2). Extrapolation of
the intersection points to the abscissa indicated that 25 nM
actin saturated 30 nM AVP and that 57 nM actin saturated 60
nM AVP. Therefore, the stoichiometry of binding was 1:1,
and the Kd, as opposed to apparent Kd, was 4.2 nM (Table 1).
3.3. Comparison of the cofactor activity of actin to that of viral
cofactors
How does the cofactor activity of actin compare to that of
pVIc? The macroscopic kinetic constants, Km and kcat, for the
hydrolysis of (Leu-Arg-Gly-Gly-NH)2-rhodamine by AVP in
the presence of di¡erent cofactors were measured (Table 1).
With AVP alone, in the absence of cofactors, the Km is 95 WM
and the kcat is 0.002 s31 [7]. With pVIc and AVP, the Km was
9.9 WM and the kcat was 0.27 s31. The data with actin and
AVP are shown in the form of an Eadie^Hofstee plot (Fig. 3).
The Km was 0.34 WM and the kcat was 0.22 s31. Actin was a
better cofactor than pVIc, based upon the speci¢city constant,
kcat/Km, 645 000 M31 s31 for actin and 27 400 M31 s31 for
pVIc.
3.4. Stimulation of AVP activity by a peptide containing the C-
terminal 11-amino acids of actin, in the presence of DNA
Since the C-terminus of actin is homologous to pVIc, the
question arose as to whether the peptide containing the last 11
amino acids at the C-terminus of actin (SGPSIVHRKCF),
abbreviated 11-Actin-C, would stimulate AVP activity. In-
creasing concentrations of 11-Actin-C were added to a con-
stant amount of AVP and the rate of substrate hydrolysis
measured. Minimal stimulation of enzyme activity was ob-
served (Fig. 4). As a control, a similar experiment was done
Fig. 2. Stoichiometry of binding of actin to AVP. Reactions con-
taining either 30 (b) or 60 (a) nM AVP were incubated with in-
creasing concentrations of actin. After incubation for 5 min at
37‡C, (Leu-Arg-Gly-Gly-NH)2-rhodamine was added to 3 WM and
the increase in £uorescence with time measured. The solid lines were
drawn with a least squares regression analysis. The dashed lines
were drawn from the intersection of the solid lines to the abscissa.
Table 1
Equilibrium dissociation constants and macroscopic kinetic constants
Kd (WM) Km (WM) kcat (s31) kcat/Km (s31 M31)
AVPa 94.8U 7.0 0.0023 4.3
Ligand binding to AVP
pVIc 3.46U 0.10 9.88U 0.025 0.271 27 400
Actin 0.00418U 0.00082 0.344U 0.025 0.222 645 000
11-Actin-C could not measure; little or no stimulation of AVP
Ligand binding to AVP(T7 DNA)
pVIc 0.049U 0.005 0.152U 0.023 2.46 16 200 000
11-Actin-C 9.52U 0.89 0.225U 0.052 2.04 9 070 000
Random-Sequence-Peptideb no stimulation of AVP activity observed
aData obtained from [7].
bAn 11-amino acid peptide with the same amino acids as in pVIc but in a sequence that was generated randomly.
Fig. 3. Macroscopic kinetic constants for the hydrolysis of substrate
by actin(AVP) complexes. Reactions containing 10 nM AVP and
100 nM actin were incubated for 5 min at 37‡C. (Leu-Arg-Gly-Gly-
NH)2-rhodamine, ranging in concentration from 0.1 to 4 WM, was
added and the increase in £uorescence with time measured. The
data are presented in an Eadie^Hofstee plot.
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but with pVIc. When the rate of substrate hydrolysis was
plotted versus the concentration of pVIc, a rectangular hyper-
bola was observed (Fig. 4); conversion of these data to
[pVIc]bound versus [pVIc]free, as described in Section 2.6,
yielded a Kd of pVIc for AVP of 3.5 WM (Table 1).
Since DNA is known to increase the a⁄nity of pVIc for
AVP [8], the above experiment to determine whether 11-Ac-
tin-C would stimulate AVP activity was repeated, but in the
presence of T7 DNA. Increasing concentrations of 11-Actin-C
were added to a constant amount of AVP and T7 DNA, and
the rate of substrate hydrolysis was measured. Under these
conditions, AVP activity was greatly stimulated by 11-Actin-
C (Fig. 5). And the degree of stimulation was proportional to
the 11-Actin-C concentration.
3.5. Kd for the binding to AVP of a peptide containing the
C-terminal 11 amino acids of actin
The Kd for the binding of 11-Actin-C to AVP in the pres-
ence of T7 DNA was determined by the same method used to
measure the Kd for the binding of actin to AVP. The data
from Fig. 5 were converted into [11-Actin-C]bound and [11-
Actin-C]free (Fig. 6A), and that graph yielded a Kd of 9.5
WM (Table 1). For comparison, the Kd for the binding of
pVIc to AVP in the presence of T7 DNA was 49 nM (Fig.
6B and Table 1).
3.6. Comparison of the cofactor activity of 11-Actin-C to that
of pVIc, in the presence of DNA
How does the cofactor activity of 11-Actin-C compare to
that of pVIc with AVP in the presence of DNA? The macro-
scopic kinetic constants for the hydrolysis of (Leu-Arg-Gly-
Gly-NH)2-rhodamine by these two forms of AVP were mea-
sured. With the AVP(T7 DNA) complex saturated with pVIc,
the Km was 0.152 WM and the kcat was 2.46 s31 (Table 1).
With the AVP(T7 DNA) complex saturated with 11-Actin-C,
the Km was 0.225 WM and the kcat was 2.04 s31 (Table 1).
Fig. 4. Stimulation of AVP activity by 11-Actin-C and by pVIc. To
10 nM AVP were added increasing concentrations of 11-Actin-C
(b) or pVIc (a). After 5 min at 37‡C, (Leu-Arg-Gly-Gly-NH)2-rho-
damine was added to 5 WM and the increase in £uorescence with
time measured.
Fig. 5. Stimulation of AVP activity by 11-Actin-C, in the presence
of T7 DNA. Increasing concentrations of 11-Actin-C were added to
60 nM AVP and 0.286 Wg/ml T7 DNA, in 10 mM Tris (pH 8.0)
and 2 mM octylglucoside. After 5 min at 37‡C, (Leu-Arg-Gly-Gly-
NH)2-rhodamine was added to 5 WM and the increase in £uores-
cence with time measured. The 11-Actin-C concentrations were 1.25
(a), 2.5 (b), 5 (E), 12.5 (F), 25 (O), 50 (R), and 100 WM (P).
Fig. 6. Binding of 11-Actin-C (A) or pVIc (B) to AVP, in the pres-
ence of T7 DNA. A: Increasing concentrations of 11-Actin-C were
added to 60 nM AVP and 0.286 Wg/ml T7 DNA. After 5 min at
37‡C, 5 WM (Leu-Arg-Gly-Gly-NH)2-rhodamine was added and the
rate of substrate hydrolysis measured. The concentrations of [11-Ac-
tin-C]bound and [11-Actin-C]free were determined as described in Sec-
tion 2. B: Increasing concentrations of pVIc were added to 20 nM
AVP and 0.286 Wg/ml T7 DNA. After 5 min at 37‡C, (Leu-Arg-
Gly-Gly-NH)2-rhodamine was added to 5 WM and the rate of sub-
strate hydrolysis measured. The concentrations of [pVIc]bound and
[pVIc]free were determined as described in Section 2.
FEBS 28240 29-3-04
M.T. Brown, W.F. Mangel/FEBS Letters 563 (2004) 213^218216
Thus, both 11-Actin-C and pVIc stimulated AVP(T7 DNA)
complexes to the same extent; the macroscopic kinetic con-
stants were similar.
3.7. Control experiments with an 11-amino acid peptide
containing a di¡erent sequence than that of pVIc
As a control, experiments similar to those described with
pVIc and 11-Actin-C were done but with a peptide that had
the same amino acid composition as in pVIc but in a di¡erent
sequence, SFRRCGLRQVK, abbreviated Random-Sequence-
Peptide. No stimulation of AVP activity was observed with
the Random-Sequence-Peptide (data not shown), either in the
absence or in the presence of T7 DNA (Table 1).
4. Discussion
These experiments were designed to characterize quantita-
tively the interaction between actin and AVP. Actin bound to
AVP with a low Kd. Secondly, AVP(actin) complexes were
shown to hydrolyze a speci¢c £uorogenic substrate with a
kcat/Km ratio higher than that exhibited by AVP(pVIc) com-
plexes. Lastly, the 11-amino acid peptide with the sequence of
the C-terminus of actin was shown in the presence of DNA to
bind to AVP and to stimulate its activity, directly demonstrat-
ing that the C-terminus of actin could be involved in the
binding of actin to AVP.
Previously, the binding of actin to AVP was measured with
actin labeled at its penultimate amino acid, Cys374, with
PRODAN [1]. The quenching of the £uorescence of PRO-
DAN indicated AVP binds at the C-terminus of actin; by
varying the AVP concentration a binding isotherm was ob-
tained from which a Kd of 1.7 WM was calculated. But, the
labeling of actin with PRODAN can a¡ect the binding of
ligand. For example, pro¢lin binds to the C-terminus of actin
but pro¢lin cannot bind to PRODAN-labeled actin [21]. For
this reason, the Kd for the binding of actin to AVP was de-
termined using unlabeled actin, and the Kd for unlabeled actin
turned out to be more than 400-fold lower than the Kd for
PRODAN-labeled actin.
There were several reasons to think a peptide with the last
11 amino acids of actin could stimulate the activity of AVP.
One reason is the high homology between the last 11 amino
acids of actin and pVIc. Two, alanine scanning mutagenesis of
pVIc has revealed that Cys10P and Phe11P of pVIc are impor-
tant in the binding of pVIc to AVP and in the stimulation of
proteinase activity [8] ; the last two amino acids in actin are
Cys374 and Phe375. The 11-amino acid residue peptide iden-
tical to the C-terminus of actin, 11-Actin-C, showed little
stimulation of AVP activity (Fig. 4). However, in the presence
of DNA, AVP activity was greatly stimulated (Fig. 5). 11-
Actin-C was shown to bind to AVP(T7 DNA) complexes
with a Kd of 9.5 WM. The macroscopic kinetic constants ex-
hibited by AVP(T7 DNA) complexes in the presence of 11-
Actin-C were the same as those exhibited by AVP(T7 DNA)
in the presence of the viral cofactor pVIc.
Why was DNA required in order for 11-Actin-C to bind to
AVP? Quite possibly more than the 11 C-terminal amino
acids of actin are required for optimal binding of actin to
AVP. DNA has been shown to suppress mutations in pVIc
that alter the ability of mutant peptides to bind to AVP [8].
For example, the Cys10PAla mutant of pVIc has a Kd much
greater than 440 WM for binding to AVP [13]. The Kd for
wild-type pVIc binding to AVP was 3.5 WM. However, in
the presence of 12-mer single-stranded DNA, the Kd for the
Cys10PAla mutant drops more than 60-fold, to 7 WM [13]. The
Kd for wild-type pVIc in the presence of DNA was 49 nM.
The homology between the last eight amino acids in actin
and the last eight amino acids of pVIc led to the prediction
that actin could act as a cellular cofactor for AVP. How
similar is actin to pVIc, as a cofactor? The Kd of actin for
AVP is 4.2 nM; that of pVIc to AVP is 3.5 WM. Once actin is
bound to AVP, the Km for substrate hydrolysis is 0.34 WM,
and the kcat is 0.22 s31 ; with AVP^pVIc, the Km is 9.9 WM
and the kcat is 0.27 s31. Thus, the Kd for actin binding to AVP
is 833-fold lower than that for pVIc binding to AVP, and the
kcat/Km is 24-fold higher. From the point of view of Kd and
kcat/Km, actin is a better cofactor than pVIc.
The Kd of 4.2 nM of actin for AVP implies, given the much
higher concentration of actin in the cytoplasm, that AVP will
bind to actin even in the presence of the multitude of actin
binding proteins present in the cytoplasm. Actin has already
been shown to be able to act in vitro as a cofactor in the
cleavage of cytokeratin 18 which contains two AVP consensus
cleavage sequences [1]. Furthermore, actin was shown to be a
cofactor and a substrate for its own destruction as incubation
of actin with AVP results in the cleavage of actin at two AVP
consensus cleavage sequences. Other cytoskeletal proteins also
contain AVP consensus cleavage sequences, including tubulin
and vimentin. Cleavage of cytoskeletal proteins has been re-
ported to weaken the mechanical structure of the cell [2], and
AVP activated by actin may play a signi¢cant role in cell lysis
and release of nascent virions.
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